Valeant Pharmaceuticals CEO: 'It's been a challenging 15 months, but we've made great progress'
August 16, 2017 at 18:26 PM EDT
Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround.
